학술논문
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial
Document Type
Article
Author
Nurdin, Asrawati; Movieta Nency, Yetty; Maddeppungeng, Martira; Sekartini, Rini; Mulia Sari, Rini; Surachman, Fikrianti; Fitry Yani, Finny; Raveinal; Anggrainy, Fenty; Hafiz, Al; Linosefa; Machmud, Rizanda; Awaliyah Deza, Putri; Rujiana, Vovinda; Bella Rahimi, Martga; Farhanah, Nur; Gundi Pramudo, Setyo; Hapsari, Rebriarina; Tri Anantyo, Dimas; Mulyono; Mahati, Endang; Maharani, Nani; Darma, Sidrah; Husni Esa Darussalam, Andi; Shakinah, Sharifah; Nasrum Massi, Muhammad; Soedjatmiko
Source
In Vaccine 30 April 2024 42(12):3009-3017
Subject
Language
ISSN
0264-410X